证券日报网讯12月29日，飞荣达（300602）在互动平台回答投资者提问时表示，公司一直高度重视行业 发展与市场变化，始终以客户需求为导向，结合自身经营实际与战略目标，审慎规划未来的战略发展方 向与业务布局。公司在持续深耕主营业务，强化内生增长的同时，也将积极寻求在技术、产品等维度与 公司战略高度协同的产业链整合机会。公司将坚持围绕既定战略稳步推进，并持续探索契合公司发展方 向的新领域，为公司的长远发展注入新动能。 ...

证券日报网讯12月25日，海顺新材（300501）在互动平台回答投资者提问时表示，公司在进行产业链整 合和并购决策时，始终以提升公司核心竞争力和长期价值为目标。公司将继续探索和评估各种投资机 会，包括高科技领域，以实现公司的长期发展和股东价值的最大化。 ...

（来源：中华工商时报） 转自：中华工商时报 2024年，大湾区企业镇海商会成立，远隔千里的两地紧密相拥，经贸合作与技术交流不断释放出乘数效 应；2025年，上海市镇海商会成立，沪镇两地文旅深度交融，进一步拓展合作空间……近年来，宁波市 镇海区委统战部以乡情为纽带，以创新为驱动，通过搭建平台、完善机制，拓展全国镇商"朋友圈"，为 区域经济发展注入活力。 乡情为弦，奏响镇商新韵 "无论走多远，只要听到商会之歌里熟悉的乡音，心里就格外踏实。"在粤港澳大湾区镇海商会季度论坛 现场，深圳优艾智合机器人科技有限公司合伙人张文杰感慨道。 "镇商情系家乡行"活动像一座桥梁，把游子与故土紧紧系在一起。来自上海、香港、广州、杭州等地的 镇海籍企业家回到家乡，漫步街头巷尾，参观文化景点时，既为家乡深厚的历史底蕴而自豪，更为蓬勃 的发展活力赞叹不已。 上海锦江国际旅游股份有限公司董事长、首席执行官郑蓓感言："家乡经济发展迅速，营商环境不断优 化，让我们对家乡充满信心与期待。" 平台赋能，护航发展征程 近年来，镇海区委统战部充分发挥镇商资源优势，组建了由80余名专业技术人才构成的"同心智库"。这 支智囊团活跃在北京中关村、深圳科技园等 ...

Core Viewpoint - Jinshi Resources announced its intention to acquire a stake in Zhejiang Noah Fluorochemical Co., marking a strategic extension into downstream fine fluorochemicals and an important move for value chain deepening and industry integration [1] Group 1: Company Overview - Jinshi Resources is a leading enterprise in the upstream fluorochemical sector, aiming to enhance its business model by integrating vertically from fluorite mining to hydrogen fluoride production and fine fluorochemical manufacturing [1] - The company has expanded its operations from fluorite resources to basic fluorochemical products, including anhydrous hydrogen fluoride and anhydrous aluminum fluoride, as well as downstream lithium battery materials like lithium hexafluorophosphate [1] Group 2: Acquisition Details - Jinshi Resources plans to acquire approximately 15.7147% of Noah Fluorochemical for a cash consideration of about 257 million yuan [1] - Upon completion of the transaction, Jinshi Resources will become the second-largest shareholder of Noah Fluorochemical, with a shareholding gap of only 0.1415 percentage points from the largest shareholder [1] Group 3: Market Position and Product Application - Noah Fluorochemical's fluorinated cooling liquid products are produced through chemical synthesis and have unique advantages in purification and testing technology [1] - The company’s products have been utilized by well-known domestic and international internet companies and server manufacturers, with an established annual production capacity of 5,000 tons of fluorinated liquids, ranking among the top in the domestic immersion liquid cooling market [1]

Core Viewpoint - Rhine Biotech plans to change its controlling shareholder to Guangzhou Defu Nutrition, with the resumption of trading on December 24, following a suspension since December 10 [2][5]. Shareholder Changes - On December 22, Rhine Biotech's current controlling shareholder Qin Benjun signed several agreements with Guangzhou Defu Nutrition, including a control change framework agreement and a share transfer agreement [8]. - Qin Benjun will transfer 8.09% of his shares to Guangzhou Defu Nutrition, relinquish 25.50% of his shares, and retain voting rights for 3% of his shares. The total transaction price is 646 million yuan, with a transfer price of 10.76 yuan per share, representing a premium of 23.68% over the closing price of 8.70 yuan on December 9 [8][9]. New Shareholding Structure - After the transaction, Qin Benjun will hold 28.50% of Rhine Biotech's shares and 4.14% of the voting rights, while Guangzhou Defu Nutrition will hold 8.09% of the shares and 11.17% of the voting rights [9]. Strategic Focus - Guangzhou Defu Nutrition, established on December 2, 2025, is controlled by Hou Ming and Li Zhenfu, and aims to leverage its resources in the healthcare sector to enhance Rhine Biotech's operational efficiency and governance structure [10]. Acquisition Plans - Rhine Biotech intends to expand its industry chain through acquisitions, specifically by issuing shares to purchase 80% of Beijing Jinkangpu Food Technology Co., Ltd. from Defu Jinkangpu and Xiamen Defu Jinkangpu [12]. - This acquisition will allow Rhine Biotech to extend its operations into the field of nutritional enhancers, creating a closed-loop industry chain from raw materials to formulation solutions [12]. Financial Overview of Beijing Jinkangpu - As of September 30, 2025, Beijing Jinkangpu reported total assets of 593 million yuan and net assets of 535 million yuan, with net profits of 70.27 million yuan and 40.33 million yuan for 2024 and the first three quarters of 2025, respectively [13][14]. Financial Overview of Rhine Biotech - As of September 30, 2025, Rhine Biotech's total assets were 4.985 billion yuan, and net assets were 3.162 billion yuan, with net profits of 16.3 million yuan and 70.40 million yuan for 2024 and the first three quarters of 2025, respectively [15].

Core Viewpoint - Rhein Biotech is undergoing a change in control, with its major shareholder transferring control to Guangzhou Defu Nutrition, effective from December 24, 2023, after a suspension of trading since December 10, 2023 [1][3]. Shareholder Changes - The controlling shareholder Qin Benjun signed several agreements with Guangzhou Defu Nutrition on December 22, 2023, including a framework agreement for control change and share transfer [3]. - Qin Benjun will transfer 8.09% of his shares in Rhein Biotech to Guangzhou Defu Nutrition and will relinquish voting rights for 25.50% of his shares while retaining voting rights for 3% [4]. - The total transaction value is 646 million yuan, with a share transfer price of 10.76 yuan per share, representing a premium of 23.68% over the closing price of 8.70 yuan on December 9, 2023 [4]. Post-Transaction Shareholding Structure - After the transaction, Qin Benjun will hold 28.50% of Rhein Biotech's shares and 4.14% of the voting rights, while Guangzhou Defu Nutrition will hold 8.09% of the shares and 11.17% of the voting rights [5]. - Guangzhou Defu Nutrition was established on December 2, 2025, by Defu Capital and currently has not engaged in any actual business activities [5]. Strategic Intentions - Rhein Biotech aims to leverage Defu Capital's extensive resources in the healthcare sector to enhance its operational efficiency and governance structure [6]. - The company plans to expand its industry chain through acquisitions, specifically targeting the nutritional supplement sector, to create a closed-loop supply chain from raw materials to formulation solutions [7]. Acquisition Details - Rhein Biotech has signed agreements to acquire 80% of Beijing Jinkangpu Food Technology Co., Ltd. through share issuance, which will be funded by issuing shares to Guangzhou Defu Nutrition [7]. - This acquisition is expected to enhance Rhein Biotech's capabilities in the nutritional supplement market, particularly in the area of fortified food products [8]. Financial Overview of Beijing Jinkangpu - As of September 30, 2025, Beijing Jinkangpu reported total assets of 593 million yuan and a net profit of 40.33 million yuan for the first three quarters of 2025 [8]. - The company is a leading supplier of nutritional supplements for infant formula manufacturers, indicating a strong market position [8]. Financial Performance of Rhein Biotech - As of September 30, 2025, Rhein Biotech's total assets were 4.985 billion yuan, with a net profit of 70.40 million yuan for the first three quarters of 2025 [10]. - The company has shown a consistent growth trajectory in its financial performance, with total liabilities of 1.823 billion yuan [10].

协同效应：技术互补与市场拓展双轮驱动 产业链上下游协同 公告披露，双方在电子核心产业链中形成互补：标的公司作为上游硬件设计企业，硬件能力突出，上市 公司则以软件算法见长，累计拥有51项信号采集与控制类软件著作权。上市公司的FOC算法、PID算法 可优化标的公司硬件性能，标的公司的高可靠性设计经验则能拓展上市公司产品军工应用场景。 登录新浪财经APP 搜索【信披】查看更多考评等级 广州思林杰科技股份有限公司（以下简称"思林杰"）近日发布《发行股份及支付现金购买资产并募集配 套资金暨关联交易申请的审核问询函之回复》，就上海证券交易所关于收购军工领域标的公司的问询事 项进行详细说明。公告显示，本次交易拟收购标的公司71%股权，交易作价13.14亿元，旨在通过产业 链整合实现军用与民用技术协同，拓展军工市场并提升上市公司核心竞争力。 交易背景与标的资产概况 根据回复函，思林杰主营工业自动化检测领域的嵌入式智能仪器模块，标的公司则专注于军工高可靠微 电路模块研发，产品覆盖电机驱动器、信号控制器等，应用于弹载、机载、舰载等特种领域。双方在技 术底层存在高度协同，均基于信号采集、电源设计、数字信号处理等核心技术，且产品形态 ...

莱茵生物（002166）12月23日晚公告，12月22日，公司控股股东、实际控制人秦本军与广州德福营养签 署了《控制权变更框架协议》《股份转让协议》《表决权放弃协议》，约定秦本军向广州德福营养协议 转让其所持上市公司6000万股股份(占公司总股本比例为8.09%)，放弃1.89亿股股份表决权(占公司总股 本比例为25.50%)，保留2224.83万股股份表决权(占公司总股本比例为3.00%)。本次协议转让完成股份过 户且公司董事会完成换届后，广州德福营养将成为公司控股股东，侯明和LIZHENFU将成为公司共同实 际控制人。 本次交易完成后，北京金康普的财务报表将纳入上市公司合并范围，本次交易的实施将改善上市公司的 资产规模、营业收入和净利润水平，有助于上市公司进一步拓展收入来源，分散整体经营风险。本次交 易是上市公司优化业务布局、提高可持续发展能力的积极举措。本次交易完成后，上市公司业务结构更 加多元，业务优势进一步扩大，促进了上市公司经营稳定性和抗风险能力。 此前，莱茵生物已自2025年12月10日开市起停牌。根据相关规定，经公司向深交所申请，公司股票将于 2025年12月24日(星期三)开市起复牌。 同日 ...

得利斯副总经理、董秘刘鹏对《证券日报》记者表示，本次股权转让旨在实现双方资源整合与优势互 补，推动公司牛肉业务"B/C双轮驱动，品牌价值突围"核心战略的顺利实施。 公告显示，宾得利专注于进口牛肉的精细化加工与食品开发，现已稳步发展成为国内中高端牛肉深加工 及预制菜领域的重要供应商之一。宾得利在生产端和产业链上下游均具备一定优势。生产端，宾得利拥 有规模化与柔性化生产能力，能满足客户对产品规格、工艺的定制化需求；供应链端，其与上游优质牛 肉供应商建立了长期稳定的合作关系，能够保障原料的品质与供应稳定性，并为成本优化提供空间；客 户端，宾得利拥有海底捞、山姆会员店、京东生鲜等众多优质客户。 本报记者 王僖 日前，山东得利斯食品股份有限公司（以下简称"得利斯"）一则转让全资子公司部分股权的公告引发投 资者关注。 公告显示，得利斯拟将其持有的全资子公司山东宾得利食品有限公司（以下简称"宾得利"）11%股权转 让给飞熊领鲜（廊坊临空自贸区）建设发展有限公司（以下简称"飞熊领鲜"），股权转让含税价格为 2530万元。交易完成后，宾得利将由得利斯全资子公司变更为控股子公司，仍纳入得利斯合并报表范 围。 刘鹏表示，对得利斯来 ...

Core Viewpoint - The announcement details a routine related-party transaction involving the sale of products worth 48.82 million yuan by the company's wholly-owned subsidiary to subsidiaries of its controlling shareholder, ensuring fair pricing and no harm to the company's independence or minority shareholders' interests [2][4][5]. Group 1: Routine Related-Party Transaction - The total amount of the routine related-party transaction is 48.82 million yuan, involving the sale of medium and low voltage switchgear and other electrical equipment [2][5]. - The transaction was approved by the company's board of directors with a unanimous vote, and independent directors confirmed that it is a normal business activity [4][12]. - The transaction does not require shareholder meeting approval as it does not exceed 5% of the company's latest audited net assets [4][10]. Group 2: Related Parties and Their Financials - Lanzhou Lande Electric Co., Ltd., a subsidiary of the controlling shareholder, has total assets of 333.11 million yuan and a net profit of -15.33 million yuan as of December 31, 2024 [7]. - Gansu Electric Equipment Group Hydropower Engineering Co., Ltd. has total assets of 12.12 million yuan and a net profit of -0.33 million yuan as of December 31, 2024 [8]. - Gansu Electric Equipment Group Industrial Engineering Co., Ltd. has total assets of 53.00 million yuan and a net profit of -16.94 million yuan as of December 31, 2024 [9]. Group 3: Purpose and Impact of Transactions - The routine related-party transactions are aimed at leveraging the resources and advantages of related parties to enhance operational efficiency and support the company's ongoing development [11][28]. - The transactions are conducted under fair market conditions, ensuring that they do not adversely affect the interests of non-related shareholders [11][29]. - The asset transfers and related transactions are part of the company's strategy to optimize resource allocation and enhance competitiveness in the market [20][39].